Discover hundreds of clinical trials for virtually all types of cancer.
Sara Erzen was at the start of her second trimester of pregnancy when she was diagnosed with breast cancer – invasive ductal carcinoma. The news was a shock to the 35-year-old wife and mother of two daughters – she was young and had no family history of breast cancer.
The lumps in her breast – dismissed for months as dense breast tissue during pregnancy – now required immediate treatment.
That’s when a family member suggested that Sara, a Lansing resident, travel to Henry Ford Cancer Institute at Henry Ford Health System for a second opinion.
During her first visit to Henry Ford Hospital in Detroit, she was met by a team of cancer specialists: oncologist Haythem Ali, M.D.; breast surgeon David Nathanson, M.D.; and radiation oncologist Eleanor Walker, M.D.
The Henry Ford Cancer Institute’s Tumor Board had already reviewed Sara’s medical records before she arrived and mapped out a comprehensive plan to treat her breast cancer both during and after her pregnancy. Two rounds of chemotherapy at Henry Ford Medical Center – Columbus in Novi while pregnant since Sara’s baby was past a critical developmental phase, followed by mastectomy surgery and radiation therapy soon after her baby is delivered.
And, on March 6, 2014, Sara’s baby, a third girl named Adeline Faith, was delivered by a team of Women’s Health experts at Henry Ford West Bloomfield Hospital.